Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Langetermijneffectiviteit van recombinant hepatitis E-vaccin bij volwassenen
jun 2024 | Hepatitis, Vaccinatie